Levram Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 21.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 15.36 Cr
as on 16-07-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.73 Cr
as on 16-07-2024
- Satisfied Charges ₹ 1.61 Cr
as on 16-07-2024
- Revenue 3.55%
(FY 2023)
- Profit -91.35%
(FY 2023)
- Ebitda -39.36%
(FY 2023)
- Net Worth 1.47%
(FY 2023)
- Total Assets 5.28%
(FY 2023)
About Levram Lifesciences
The Corporate was formerly known as Levram Plastics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 21.00 Cr and a paid-up capital of Rs 15.36 Cr.
The company currently has active open charges totaling ₹15.73 Cr. The company has closed loans amounting to ₹1.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gupta, Siddhant Saboo, and Rishabh Mehrotra serve as directors at the Company.
- CIN/LLPIN
U72300MH2015PTC267629
- Company No.
267629
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Levram Lifesciences Private Limited offer?
Levram Lifesciences Private Limited offers a wide range of products and services, including Sexual Wellness Products, Female Hygiene Products & Test Kits, Plastic & Glass Labware, Laboratory Glassware, Medical Laboratory Instruments, Corona Test Kit, Infusion Syringes & Supplies, Blood Collection Tubes, Laboratory Plasticware, Vials and Ampoules.
Who are the key members and board of directors at Levram Lifesciences?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Siddhant Saboo | Director | 21-Aug-2015 | Current |
Sanjay Gupta | Director | 01-Jan-2020 | Current |
Rishabh Mehrotra | Director | 27-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Levram Lifesciences.
Levram Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.55% increase. The company also saw a substantial fall in profitability, with a 91.35% decrease in profit. The company's net worth moved up by a moderate rise of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Levram Lifesciences?
In 2023, Levram Lifesciences had a promoter holding of 95.14% and a public holding of 4.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shivsons Resorts And Properties Private LimitedActive 36 years 2 months
Sanjay Gupta is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 05 May 2023 | ₹6.00 M | Open |
Hdfc Bank Limited Creation Date: 09 Oct 2020 | ₹1.30 M | Open |
Others Creation Date: 30 Mar 2017 | ₹15.00 Cr | Open |
How Many Employees Work at Levram Lifesciences?
Levram Lifesciences has a workforce of 226 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Levram Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Levram Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.